These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10705977)

  • 1. Biokinetic parameters and metabolism of S-benzoylthiamine-O-monophosphate.
    Ziems M; Netzel M; Bitsch I
    Biofactors; 2000; 11(1-2):109-10. PubMed ID: 10705977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristic features of 35S-benzoylthiamine monophosphate in albino mice].
    Karpov LM; Rozanov AIa; Filippova TO
    Vopr Med Khim; 1986; 32(4):136-9. PubMed ID: 3765492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of various thiamine derivatives after oral administration.
    Greb A; Bitsch R
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):216-21. PubMed ID: 9587048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
    Hurt JK; Coleman JL; Fitzpatrick BJ; Taylor-Blake B; Bridges AS; Vihko P; Zylka MJ
    PLoS One; 2012; 7(10):e48562. PubMed ID: 23119057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
    Frank T; Bitsch R; Maiwald J; Stein G
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):449-55. PubMed ID: 10507244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the transdermal delivery of benfotiamine.
    Zhu Z; Varadi G; Carter SG
    Acta Diabetol; 2016 Apr; 53(2):317-22. PubMed ID: 26141141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.
    Bitsch R; Wolf M; Möller J; Heuzeroth L; Grüneklee D
    Ann Nutr Metab; 1991; 35(5):292-6. PubMed ID: 1776825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate.
    Schreeb KH; Freudenthaler S; Vormfelde SV; Gundert-Remy U; Gleiter CH
    Eur J Clin Pharmacol; 1997; 52(4):319-20. PubMed ID: 9248773
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of high-dosed thiamine hydrochloride and S-benzoyl-thiamine-O-monophosphate on thiamine-status after chronic ethanol administration.
    Netzel M; Ziems M; Jung KH; Noll E; Borsch C; Bitsch I
    Biofactors; 2000; 11(1-2):111-3. PubMed ID: 10705978
    [No Abstract]   [Full Text] [Related]  

  • 10. A new thiamine derivative, S-benzoylthiamine O-monophosphate.
    WADA T; TAKAGI H; MINAKAMI H; HAMANAKA W; OKAMOTO K; ITO A; SAHASHI Y
    Science; 1961 Jul; 134(3473):195-6. PubMed ID: 13782394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
    Frank T; Bitsch R; Maiwald J; Stein G
    Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver, plasma and erythrocyte levels of thiamine and its phosphate esters in rats with acute ethanol intoxication: a comparison of thiamine and benfotiamine administration.
    Portari GV; Vannucchi H; Jordao AA
    Eur J Pharm Sci; 2013 Mar; 48(4-5):799-802. PubMed ID: 23369791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and biological activity of a thiamine new salt. I. Urinary excretion and tissue content of vitamin B1 in rats treated with thiamine chloride ester monophosphate of Bis-glucosamine.
    Marchi M; Rossi G
    Int J Vitam Nutr Res; 1978; 48(2):136-9. PubMed ID: 689808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of various reducing compounds on the thiamine activity of S-benzoylthiamine O-monophosphate.
    HIRAOKA E; SHIMAMOTO T
    J Vitaminol (Kyoto); 1962 Sep; 8():201-5. PubMed ID: 13954737
    [No Abstract]   [Full Text] [Related]  

  • 15. [The uptake and the distribution of thiamine propyl disulfide-35S by the rabbit's eye tissue].
    Miura S
    Nippon Ganka Gakkai Zasshi; 1965 Jul; 69(7):792-807, discussion 807-8. PubMed ID: 5006719
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride.
    Xie F; Cheng Z; Li S; Liu X; Guo X; Yu P; Gu Z
    J Clin Pharmacol; 2014 Jun; 54(6):688-95. PubMed ID: 24399744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain transport of thiamine monophosphate in the rat: a kinetic study in vivo.
    Patrini C; Reggiani C; Laforenza U; Rindi G
    J Neurochem; 1988 Jan; 50(1):90-3. PubMed ID: 3335853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COMPARATIVE STUDY OF BLOOD THIAMINE CONTENT AFTER ADMINISTRATION OF THIAMINE HYDROCHLORIDE AND BENZOYLTHIAMINE MONOPHOSPHATE].
    SAMPEREZ S; JOUAN P; DUTHIL J
    Therapie; 1965; 20():453-7. PubMed ID: 14326893
    [No Abstract]   [Full Text] [Related]  

  • 19. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
    Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of thiamine by brush-border membrane vesicles from rat small intestine.
    Casirola D; Ferrari G; Gastaldi G; Patrini C; Rindi G
    J Physiol; 1988 Apr; 398():329-39. PubMed ID: 3392675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.